Search research articles
Contact Us
Filters
Showing results (101-110 of 208) with videos related to
Page
of 21
Sort By:
Expert Review of Respiratory Medicine
|
September 30, 2023
Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics
Yuda Zhang, Fanxu Zeng, Shixuan Peng, et al.
Translational Lung Cancer Research
|
January 20, 2025
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with <i>BRAF</i> <sup>V600E</sup> mutation-positive metastatic non-small cell lung cancer
Yun Fan, Jianying Zhou, Yuanyuan Zhao, et al.
Frontiers in Immunology
|
June 23, 2023
Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
Chaoyuan Liu, Liang Zeng, Chao Deng, et al.
BMC Cancer
|
May 15, 2023
Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study
Lianxi Song, Fei Zhou, Tian Xu, et al.
Journal of Translational Medicine
|
December 12, 2025
Tumor immune microenvironment score predicts efficacy of immune checkpoint inhibitors-based regimens in advanced non-small cell lung cancer
Jiacheng Dai, Huan Yan, Yangqian Chen, et al.
Clinical Lung Cancer
|
August 9, 2025
Clinical Outcomes of Patients With Advanced ALK-Rearranged Lung Squamous Cell Carcinoma Treated With ALK Tyrosine Kinase Inhibitors
Yuanze Sun, Dan Yang, Zhe Huang, et al.
Virology Journal
|
April 10, 2013
Phylogenetic analysis of the haemagglutinin gene of canine distemper virus strains detected from giant panda and raccoon dogs in China
Ling Guo, Shao-lin Yang, Cheng-dong Wang, et al.
Signal Transduction and Targeted Therapy
|
July 14, 2024
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study
Ziming Li, Zhengbo Song, Wei Hong, et al.
Frontiers in Pharmacology
|
November 24, 2025
Anlotinib added to third generation EGFR tyrosine kinase inhibitor therapy for advanced NSCLC patients with oligo-progression: a retrospective study (ALTER-L058)
Fei Zhou, Minglei Zhuo, Hongmin Wang, et al.
Forensic Science International. Genetics
|
February 3, 2026
Metagenomic profiling reveals lung multi-kingdom microbes as forensic markers for aquatic corpses investigation
Fu-Yuan Zhang, Du Shu-Kui, Lin-Lin Wang, et al.
Page
of 21
Search research articles
Search
Showing results (101-110 of 208) with videos related to
Sort By:
Page
of 21
Expert Review of Respiratory Medicine
|
September 30, 2023
Stratification of patients with KRAS-mutated advanced non-small cell lung cancer: improving prognostics
Yuda Zhang, Fanxu Zeng, Shixuan Peng, et al.
Translational Lung Cancer Research
|
January 20, 2025
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with <i>BRAF</i> <sup>V600E</sup> mutation-positive metastatic non-small cell lung cancer
Yun Fan, Jianying Zhou, Yuanyuan Zhao, et al.
Frontiers in Immunology
|
June 23, 2023
Hypofractionated radiotherapy with immunochemotherapy for extensive-stage small-cell lung cancer
Chaoyuan Liu, Liang Zeng, Chao Deng, et al.
BMC Cancer
|
May 15, 2023
Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study
Lianxi Song, Fei Zhou, Tian Xu, et al.
Journal of Translational Medicine
|
December 12, 2025
Tumor immune microenvironment score predicts efficacy of immune checkpoint inhibitors-based regimens in advanced non-small cell lung cancer
Jiacheng Dai, Huan Yan, Yangqian Chen, et al.
Clinical Lung Cancer
|
August 9, 2025
Clinical Outcomes of Patients With Advanced ALK-Rearranged Lung Squamous Cell Carcinoma Treated With ALK Tyrosine Kinase Inhibitors
Yuanze Sun, Dan Yang, Zhe Huang, et al.
Virology Journal
|
April 10, 2013
Phylogenetic analysis of the haemagglutinin gene of canine distemper virus strains detected from giant panda and raccoon dogs in China
Ling Guo, Shao-lin Yang, Cheng-dong Wang, et al.
Signal Transduction and Targeted Therapy
|
July 14, 2024
SHR-A1811 (antibody-drug conjugate) in advanced HER2-mutant non-small cell lung cancer: a multicenter, open-label, phase 1/2 study
Ziming Li, Zhengbo Song, Wei Hong, et al.
Frontiers in Pharmacology
|
November 24, 2025
Anlotinib added to third generation EGFR tyrosine kinase inhibitor therapy for advanced NSCLC patients with oligo-progression: a retrospective study (ALTER-L058)
Fei Zhou, Minglei Zhuo, Hongmin Wang, et al.
Forensic Science International. Genetics
|
February 3, 2026
Metagenomic profiling reveals lung multi-kingdom microbes as forensic markers for aquatic corpses investigation
Fu-Yuan Zhang, Du Shu-Kui, Lin-Lin Wang, et al.
Page
of 21